Guiding a company through a merger or an acquisition can test a CEO’s leadership skills. Here’s how NinePoint Medical CEO, Christopher von Jako, led his former medtech company, NeuroTherm, through a deal with St. Jude Medical. When Christopher von Jako assumed the corner office at NeuroTherm in 2013, the company had gone through two other […]
S2N recently hosted an informal gathering of emerging med tech CEOs, a sort of group therapy session for people suffering from the form of temporary insanity that makes one want to be a healthcare entrepreneur.
ArthroCare Corp. (NSDQ:ARTC) sold its Parallax and Contour product lines to NeuroTherm for $5.5 million.
The two lines of spine products were previously reported as discontinued operations.
Wilmington, Mass.-based NeuroTherm manufactures products used in pain management, including the first multi-lesion radiofrequency generator on the market, according to a company release.
NeuroTherm added another asset to its portfolio of pain management products with yet another acquisition, this time of Smith & Nephew plc’s (NYSE:SNN) interventional spine pain management line.
The deal, for an undisclosed amount, brings Smith & Nephew’s CDS discography system, SpineCath and AcuTherm catheters and a full radiofrequency product line under Wilmington, Mass.-based NeuroTherm’s umbrella. The deal also calls for NeuroTherm to distribute Smith & Nephew’s TruCath injection system. Financial terms were not disclosed.
NeuroTherm Inc. added to its portfolio of pain management technologies with the acquisition of some of a European company’s needle lines.
The Wilmington, Mass.-based medical device maker paid an undisclosed amount for Dutch firm Technomed Europe’s intellectual property and manufacturing know-how "associated with certain needle product lines," according to a press release.
NeuroTherm bought Micron Catheter last summer for an undisclosed amount, adding the Palm Beach gardens, Fla.-based company’s epidural scar removal catheter to its holdings.